[Molecular bases of dystrophinopathies]

Area of Science:

• Genetics
• Molecular Biology
• Neurology

Background:

• Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder affecting 1 in 3500 males.
• Despite its rarity, DMD is a common myopathy found globally.
• The discovery of the dystrophin gene in 1986 revolutionized understanding of DMD.

Purpose of the Study:

• To review advances in understanding Duchenne muscular dystrophy since the dystrophin gene identification.
• To discuss the impact of gene discovery on molecular diagnostics for DMD.
• To explore current and future therapeutic strategies for DMD.

Main Methods:

• Literature review of scientific publications on Duchenne muscular dystrophy.
• Analysis of the impact of dystrophin gene discovery on diagnostic approaches.
• Evaluation of therapeutic prospects and research directions for DMD.

Main Results:

• Identification of the dystrophin gene in 1986 as the cause of DMD.
• Significant progress in molecular diagnosis at both protein and DNA levels.
• Lack of effective treatments despite decades of research.

Conclusions:

• The dystrophin gene discovery was a landmark in DMD research, enabling precise molecular diagnostics.
• Current therapeutic strategies for DMD are limited, highlighting an urgent need for effective treatments.
• Continued research into therapeutic prospects is crucial for improving outcomes for individuals with DMD.